As of 2026-09-29, the EV/EBITDA ratio of Insmed Inc (INSM) is -31.55. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INSM's latest enterprise value is 25,686.00 mil USD. INSM's TTM EBITDA according to its financial statements is -814.13 mil USD. Dividing these 2 quantities gives us the above INSM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 20.7x | 15.8x |
| Forward P/E multiples | 12.7x - 16.7x | 14.3x |
| Fair Price | (52.22) - (63.41) | (57.27) |
| Upside | -144.4% - -153.9% | -148.7% |
| Date | EV/EBITDA |
| 2026-09-25 | -31.59 |
| 2026-09-24 | -32.58 |
| 2026-09-23 | -31.73 |
| 2026-09-22 | -32.39 |
| 2026-09-21 | -32.44 |
| 2026-09-18 | -32.17 |
| 2026-09-17 | -33.23 |
| 2026-09-16 | -32.86 |
| 2026-09-15 | -32.15 |
| 2026-09-14 | -33.58 |
| 2026-09-11 | -34.68 |
| 2026-09-10 | -34.11 |
| 2026-09-09 | -34.51 |
| 2026-09-08 | -33.47 |
| 2026-09-04 | -33.85 |
| 2026-09-03 | -33.95 |
| 2026-09-02 | -33.94 |
| 2026-09-01 | -32.57 |
| 2026-08-31 | -32.66 |
| 2026-08-28 | -31.78 |
| 2026-08-27 | -32.54 |
| 2026-08-26 | -33.34 |
| 2026-08-25 | -33.21 |
| 2026-08-24 | -33.23 |
| 2026-08-21 | -33.71 |
| 2026-08-20 | -33.52 |
| 2026-08-19 | -35.01 |
| 2026-08-18 | -34.42 |
| 2026-08-17 | -34.39 |
| 2026-08-14 | -33.17 |
| 2026-08-13 | -33.86 |
| 2026-08-12 | -35.44 |
| 2026-08-11 | -35.52 |
| 2026-08-10 | -36.10 |
| 2026-08-07 | -35.13 |
| 2026-08-06 | -35.51 |
| 2026-08-05 | -26.58 |
| 2026-08-04 | -26.51 |
| 2026-08-03 | -26.43 |
| 2026-07-31 | -26.47 |
| 2026-07-30 | -27.24 |
| 2026-07-29 | -27.68 |
| 2026-07-28 | -27.95 |
| 2026-07-27 | -28.11 |
| 2026-07-24 | -28.69 |
| 2026-07-23 | -28.82 |
| 2026-07-22 | -28.61 |
| 2026-07-21 | -29.14 |
| 2026-07-20 | -28.71 |
| 2026-07-17 | -29.06 |